The Department of Endocrinology is a tertiary referral centre which provides specialised and holistic care for conditions involving the hormone-producing endocrine glands. These include diabetes mellitus, obesity, cholesterol disorders, and disorders of bone, thyroid, pituitary, adrenal and reproductive glands.
We operate from the
Diabetes, Obesity, Metabolism and Endocrine Centre (DOME), which provides specialist care to manage patients with endocrine conditions and diabetes mellitus.
Changi General Hospital (CGH) is one of the ACGME accredited centres for advanced training in Endocrinology. The SingHealth Endocrinology program is a structured three-year program that equips trainees with the medical knowledge, interpersonal skills, professional attitudes, and practical competence required to be an Endocrinologist.
here to find out more.
Our specialists serve as clinical tutors and active contributors to undergraduate medical training for the Yong Loo Lin School of Medicine, Duke-NUS Graduate Medical School, as well as the Lee Kong Chian School of Medicine.
Our clinicians specialise in patients with secondary hypertension. Patients with secondary hypertension have an underlying cause that can be treated, leading to improvement or cure of hypertension. In particular, 5 to 10% of all patients with hypertension in Singapore have this condition, which is otherwise known as Primary Aldosteronism. Primary Aldosteronism is a disease of the adrenal glands (small glands above the kidney), which is treatable. Patients with a curable form of Primary Aldosteronism are currently diagnosed through adrenal vein sampling. We currently have adrenal vein sampling rates of more than 95% over the last five years and are constantly looking at ways to improve care further.
In line with this, we are recipient of a national grant using a new non-invasive scan, 11C-metomidate PET/CT, to identify patients with this curable form of hypertension. We are collaboratively working with all the other restructured hospitals and we hope to continue to provide quality care for our patients with hypertension.
Clinicians involved in the care of osteoporosis and bone metabolic diseases also take part in clinical research for the improvement of treatment regarding osteoporosis and its complications. We work together with the multidisciplinary team of the “Valued Care Hip Fracture” unit to provide holistic care for our osteoporosis patients with hip fractures, and reduce complications post hip fracture. It is hoped that through continuous improvement and research, better patient care will be delivered to the community.
Our main research areas include the following :
The Osteoporosis and Bone Metabolism Unit has ongoing research collaborations with multiple departments within Changi General Hospital (CGH) including Orthopedic, Geriatric, Rehabilitation, Radiology and various allied health disciplines. We are also partners in pharmaceutical trials for the ongoing research of Osteoporosis Treatments through our CGH Centre for Trials and Research Unit. Future collaborations are welcomed and we look forward to hearing from interested partners.
Our main research areas include:
2 Simei Street 3,
(65) 6788 8833
(65) 6788 0933
Changi General Hospital (CGH)